Atracurium Besylate Injection

Company
Faulding

Approval Status
Approved April 1997

Treatment for
muscle relaxant

Areas
Musculoskeletal

Preserved and unpreserved forms of Atracurium Besylate Injection, an intermediate duration muscle relaxant, have been approved for marketing. The drugs are the generic equivalents of Tracrium, an adjunct to general anesthesia during surgery or mechanical ventilation that is marketed by GlaxoWellcome.

Atracurium_besylate_injection Drug Information

The Atracurium_besylate_injection drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top